Mangoceuticals Inc. – Filings and Transcripts

NASDAQ: MGRX
Share price (6/8/26): $0.36
Market cap (6/8/26): $6.232 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 03/31/26 Q1

Late quarterly filing notification for Q1 2026

ended 12/31/25 FY 2025

Late annual filing notification for FY 2025

ended 09/30/25 Q3

Prospectuses and Registrations Filter

Initial registration of new securities – amended

Initial registration of new securities

Prospectus supplement for primary offering

Shelf registration

Initial registration of new securities

Ownership Filter

Cohen Jacob D., Tiger Cub Trust

Cohen Jacob D., Tiger Cub Trust

Johnston Eugene M

Johnston Eugene M

Johnston Eugene M

News Filter

Announces Lawsuit Seeking Damages Exceeding $73 Million Against Former Technology Consulting and Software Development Firm, Clarity Ventures, Inc

Mangoceuticals’ Patented MGX-0024 Achieves Zero Respiratory-Related Mortality in 29,000-Bird Field Trials and Demonstrates Prophylactic Benefit Against H5N1 in Controlled Government Study

MangoRx Experiences Initial Success With Newly Launched $99/Month All-Inclusive Injectable Testosterone Replacement Therapy (TRT) Treatment Program

Notice of Delisting, Failure to Satisfy Listing Rule, or Transfer of Listing

Announces $2.5 Million Registered Direct and Private Placements Priced at the Market Under Nasdaq Rules

Proxies Filter

Definitive proxy

Preliminary proxy

Definitive proxy

Preliminary proxy

Definitive proxy

Other Filter

Notice of effectiveness

Letter from the SEC

Correspondence with the SEC

Notice of effectiveness

Correspondence with the SEC